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provided it is propeObjectives: National population-wide HIV prevalence and incidence trends in sub-
Saharan Africa (SSA) are indirectly estimated using HIV prevalence measured among
pregnant women attending antenatal clinics (ANC), among other data. We evaluated
whether recent HIV prevalence trends among pregnant women are representative of
general population trends.
Design: Serial population-based household surveys in 13 SSA countries.
Methods: We calculated HIV prevalence trends among all women aged 15–49 years
and currently pregnant women between surveys conducted from 2003 to 2008
(period 1) and 2009 to 2012 (period 2). Log-binomial regression was used to test for
a difference in prevalence trend between the two groups. Prevalence among pregnant
women was age-standardized to represent the age distribution of all women.
Results: Pooling data for all countries, HIV prevalence declined among pregnant
women from 6.5 [95% confidence interval (CI) 5.3–7.9%] to 5.3% (95% CI 4.2–
6.6%) between periods 1 and 2, whereas it remained unchanged among all women at
8.4% (95% CI 8.0–8.9%) in period 1 and 8.3% (95% CI 7.9–8.8%) in period 2.
Prevalence declined by 18% (95% CI 9–38%) more in pregnant women than
nonpregnant women. Estimates were similar in Western, Eastern, and Southern regions
of SSA; none were statistically significant (P>0.05). HIV prevalence decreased sig-
nificantly among women aged 15–24 years while increasing significantly among
women 35–49 years, who represented 29% of women but only 15% of pregnant
women. Age-standardization of prevalence in pregnant women did not reconcile the
discrepant trends because at older ages prevalence was lower among pregnant women
than nonpregnant women.
Conclusion: As HIV prevalence in SSA has shifted toward older, less-fertile women,
HIV prevalence among pregnant women has declined more rapidly than prevalence in
women overall. Interpretation of ANC prevalence data to inform national HIV estimates
should account for both age-specific fertility patterns and HIV-related sub-fertility.
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S508 AIDS 2014, Vol 28 (Suppl 4)IntroductionThe establishment of sentinel surveillance of HIV
prevalence among pregnant women attending antena-
tal clinics (ANC) in the early 1990s in countries
with generalized HIV epidemics in sub-Saharan
Africa [1] enabled HIV to become one of the
better-quantified disease burdens in global health
[2]. These prevalence surveys are repeated in the
same clinics every 1–2 years and HIV prevalence
estimates derived from women attending sentinel
ANC have been used as a proxy measure to estimate
the levels and trends in HIV prevalence among all
adults aged 15–49 years using mathematical models
[3–6]. In addition, data from these surveys are used to
indirectly derive estimates of HIV incidence using
mathematical models that incorporate other infor-
mation about survival after HIV infection and anti-
retroviral use [7,8].
Since 2001, national household surveys including
HIV testing, such as the Demographic and Health
Surveys (DHS) and AIDS Indicator Surveys (AIS),
have provided statistically representative estimates
of population-wide adult HIV prevalence, includ-
ing men and nonpregnant women. Based on the
assumption that household prevalence surveys provide
an unbiased estimate of HIV prevalence in the general
population, these data have been used to calibrate
the level of HIV prevalence estimates derived from
ANC sentinel surveillance [9]. But, because such
household HIV prevalence surveys are less frequent
and, until recently, few countries had conducted
more than one, ANC surveillance has continued to
be relied upon as the primary information source for
estimating the HIV epidemic trend in the general
population.
The veracity of estimates derived from ANC prevalence
data thus relies on the assumption that HIV prevalence
trends among women attending ANC are representative
of HIV trends among all adults aged 15–49 years. Two
recent epidemiologic phenomena particularly motivate
investigation of this assumption: recent declines in HIV
incidence being especially great among younger adults
[10,11] and the scale-up of antiretroviral treatment,
which has resulted in treated persons living with HIV to
older ages than they might have previously. Both
changes could have shifted the age-distribution of
prevalent HIV infections to older age groups, who are
less fertile and thus less represented in ANC surveillance
[12].
We pool data from serial cross-sectional household
surveys in sub-Saharan Africa to compare recent trends in
HIV prevalence between all women and women
currently pregnant at the time of the survey.Methods
Data
We used nationally representative household-based HIV
prevalence survey data from countries in sub-Saharan
Africa with at least two surveys in which women’s HIV
serostatus could be linked to her self-reported pregnancy
status at the time of the survey. All surveys were
conducted using a stratified two-stage cluster design. In
most countries, these consist of DHS and AIS [13]. For
South Africa, we used data from the HSRC National
HIV Prevalence, Incidence, and Behaviour Surveys
[14,15]. For Swaziland, we compared data from the
2007 DHS to estimates from the 2011 Swaziland HIV
Incidence Measurement Survey [16]. In Swaziland, data
were for women aged 18–49 years, the sampling frame
for the latter survey. In all other countries, we restricted
analysis to women aged 15–49 years, the age-range for
which ANC prevalence trend is assumed to be
representative in the Joint United Nations Programme
on HIV/AIDS (UNAIDS) global HIV estimates [8].
To analyze HIV trends over time, we divided surveys into
two periods with each country having one survey in
each period. All surveys during the first period were
conducted between 2003 and 2008 and all surveys during
the second period between 2009 and 2012. In countries
with more than two available surveys (Kenya, South
Africa, Tanzania), we used the two most recent surveys.
Table 1 summarizes the countries, year conducted, and
sample sizes for each of the surveys included in the
analysis.
We combined data from multiple countries into SSA
regions according to standard UNAIDS classifications
(Western, Eastern, Southern), and all countries together.
For pooled multicountry analyses, survey sampling
weights were de-normalized using the population size
for women aged 15–49 years in 2012 from the UNWorld
Population Prospects 2012 [17]. Thus, regional and
continental pooled statistics and trends are representative
of the aggregated population of the countries included in
the analysis.
Statistical analysis
We calculated the percentage of women currently
pregnant at the time of the survey. We calculated HIV
prevalence among all women and currently pregnant
women in each time period. Ninety five percentage
(95%) confidence intervals for proportions were calcu-
lated using the logit method. Prevalence trends among all
women aged 15–49 years and men aged 15–49 years
were also compared.
We tested for a difference in recent HIV prevalence trends
between pregnant and not currently pregnant women
by estimating a log-binomial regression model with an
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.interaction between survey period and pregnancy status at
the time of the survey. Country-level fixed-effects were
included in regressions to adjust for different fertility
levels across countries:
logðPðHIVþÞÞ ¼ b0i  ½countryi þ b1  ½pregnant
þ b2  ½period ¼ 2
þ b3  ½pregnant  ½period ¼ 2
The regressionwas also estimated separately for women in
age groups 15–24 years, 25–34 years, and 35–49 years to
evaluate prevalence differences between pregnant and
nonpregnant women in each age group. We standardized
the age distributions of the two prevalence measures by
re-weighting the 5-year age-specific prevalence among
pregnant women according to the age distribution of all
women in the general population.
Analyses were conducted in R version 3.1.0 [18] using
the ‘survey’ package [19] to account for the stratified two-
stage cluster sampling design of the surveys. R code for
reproducing analyses is available at https://github.com/
jeffeaton/currpreg-hiv-trends.Results
Age distribution of fertility and changes in age-
specific prevalence
Figure 1a compares the age distribution of all women in
the population and the age distribution of currently
pregnant women. Figure 1b illustrates changes in age-
specific HIV prevalence among women aged 15–49 years
between surveys conducted in period 1 (2003–2008) and
period 2 (2008–2012). Younger adult women were
disproportionately represented among currently pregnant
women. Across all countries, women aged 15–34 years
accounted for 85% of pregnant women compared with
only 71% of the overall female population. Results were
similar in each region: 86 versus 73% in Western Africa,
85 versus 72% in Eastern Africa, and 85 versus 69% in
Southern Africa. There was not a statistically significant
change in the age distribution of currently pregnant
women between periods 1 and 2.
Between periods 1 and 2, HIV prevalence shifted to
older ages (Fig. 1b). Among women aged 15–24 years,
HIV prevalence decreased significantly from 5.1 (95%CI
4.6–5.5%) to 3.6% (95% CI 3.2–3.9%) and among those
aged 35–49 years increased significantly from 9.4 (95%
CI 8.7–10.2%) to 11.7% (95% CI 10.9–12.7%). This
pattern was the same in all three regions (Fig. 1b). Taken
together, HIV prevalence has declined among the age
groups of women who are overrepresented among
samples of pregnant women, whereas it increased among
age groups underrepresented among samples of pregnant
women.
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Fig. 1. (a) Age distribution of all women aged 15–49 years and currently pregnant women (both periods combined). (b) Age-
specific HIV prevalence among all women aged 15–49 years in period 1 (surveys conducted 2003–2008) and period 2 (surveys
2008–2012). Shaded regions indicate 95% confidence intervals. Note vertical axes are not the same in (b).Prevalence trends between pregnant women and
all women
Figure 2a illustrates the HIV prevalence trend in each
country among all women aged 15–49 years and
currently pregnant women. Point estimates in 11 of
13 countries indicated that between the two most recent
surveys HIV prevalence declined more or increased less
among currently pregnant women than all women
(Fig. 2b) Note that the standard errors for the change
HIV prevalence among pregnant women are large
(Fig. 2a; Table S1, http://links.lww.com/QAD/A559),
and the difference in prevalence trend is not statistically
significant in any country. Relative changes in prevalence
among adult men aged 15–49 years were similar on
average to relative prevalence changes in adult women
(Figure S1, http://links.lww.com/QAD/A559 ).
Pooling all countries, HIV prevalence among currently
pregnant women declined from 6.5 (95% CI 5.3–7.9%)
to 5.3% (95% CI 4.2–6.6%), a 19% decline, whereas it
remained relatively unchanged at 8.4% (95% CI 8.0–
8.9%) in period 1 to 8.3% (95% CI 7.9–8.8%) in period 2
among all women aged 15–49 years. In Western Africa,
prevalence among pregnant women declined from 4.3
(95% CI 3.4–5.4%) to 2.9% (95% CI 2.2–3.9%) among
pregnant women and 4.0 (95% CI 3.7–4.4) to 3.4% (95%
CI 3.1–3.7%) among all women, in Eastern Africa from
3.6 (95% CI 2.6–4.9) to 2.9 (95% CI 2.2–3.9) for
pregnant women and 4.5 (95% CI 4.1–4.9%) to 4.1%
(95% CI 3.8–4.5%) for all women, and in Southern
Africa from 17.3% (95% CI 12.8–22.9%) to 16.1% (95%
CI 11.6–22.0%) for pregnant women and increased from
20.1% (95% CI 18.8–21.4%) to 20.9% (95% CI 19.6–
22.3%) for all women (Table S1, http://links.lww.com/
QAD/A559).Adjusting for country, HIV prevalence was lower among
currently pregnant women than nonpregnant women
during period 1 [relative risk (RR) 0.89, 95% CI 0.73–
1.08; Table 2]. Based on the estimated interaction
between current pregnancy and survey period, preva-
lence among pregnant women declined 18% more than
prevalence among nonpregnant women between periods
1 and 2 (RR 0.82, 0.62–1.09; Table 2). The same pattern
was found in all regions, with the prevalence trend among
pregnant women being lower than that for all women by
22, 21, and 13% in Western, Eastern and Southern
regions, respectively, although none were statistically
significant (Western: RR 0.78, 0.54–1.14; Eastern: 0.79,
0.51–1.22; Southern 0.87; 0.57–1.33).
Age-standardized prevalence and age-specific
prevalence trends among pregnant women
Based on the discrepancy in the age-distribution of preg-
nant women compared with all women (Fig. 1a), a natural
approach to adjusting for the bias in prevalence among
pregnantwomenwould be to re-weight age-specificANC
prevalence with the population age distribution. Figure 2c
illustrates the effect of age-standardizing prevalence
among pregnant women on the estimated prevalence
trend. Pooling all countries, the relative change in age-
standardized prevalence was somewhat more similar to the
change in general population prevalence, but not
substantially so; age standardized prevalence declined
by 17.4% compared with a 18.8% decline in crude
prevalence among pregnant women. Standard error
estimates for age-standardized prevalence among preg-
nant women were large, similar to the standard errors for
crude prevalence among pregnant women (Table S1,
http://links.lww.com/QAD/A559), preventing formal
comparison of trends in age-standardized prevalence.
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standardized prevalence among pregnant women.Furthermore, age-standardization increased the extent to
which HIV prevalence among pregnant women under-
estimated HIV prevalence for all women. For example,
pooling all countries, in period 1, age-standardization
reduced HIV prevalence among currently pregnant
women from 6.5 to 5.5%, compared with a prevalence
of 8.4% among all women aged 15–49 years (Table S1,
http://links.lww.com/QAD/A559).Table 2. Log-binomial regression estimating the relationship between HI
Western
Currently pregnant vs. not 1.04 (0.82, 1.33) 0.80
Period 2 vs. period 1 0.86 (0.75, 0.98) 0.93
Currently pregnant  period 2a 0.78 (0.54, 1.14) 0.79
Estimates indicate relative risk ratios (RR) and 95% confidence intervals, a
aInteraction between current pregnancy and survey period estimates exce
women vs. not currently pregnant women.The increased discrepancy in age-standardized prevalence
was explained by examining the age-specific prevalence
trends between pregnant women and all women (Fig. 3).
Among young women aged 15–24 years, levels and HIV
prevalence among pregnant women were representative
of all women. However, among women aged 25–34 years
and 35–49 years, prevalence was lower among pregnant
women than all women. Adjusting for country-levelV prevalence and current pregnancy and survey period.
Eastern Southern All
(0.59, 1.09) 0.89 (0.66, 1.20) 0.89 (0.73, 1.08)
(0.82, 1.05) 1.04 (0.95, 1.13) 0.99 (0.93, 1.06)
(0.51, 1.22) 0.87 (0.57, 1.33) 0.82 (0.62, 1.09)
djusted for country.
ss prevalence decline in HIV prevalence among currently pregnant
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Fig. 3. Trends in age-specific prevalence among pregnant
women and all women by age group and region.differences in fertility, for women 25–34 years, HIV
prevalence was 24% (95% CI -4–45%) lower among
pregnant women than nonpregnant women in period 2.
For women aged 35–49 years, prevalence was 54% (36–
79%) lower among pregnant women (data not shown).Discussion
Observed reductions in HIV prevalence in ANC
surveillance systems may exaggerate the extent of HIV
prevalence declines that are occurring in the wider female
population. This is because HIV epidemics in sub-
Saharan Africa are aging into older age groups of women,
who experience lower fertility and thus are likely to be
less represented among ANC clinic attendees. This is
consistent across all three sub-Saharan regions ofWestern,
Eastern and Southern Africa, and this pattern will be
expected to continue and be exacerbated as ART
programmes mature and HIV positive patients survive
to older ages.
Point estimates in all three regions suggested that
prevalence declined more rapidly among currently
pregnant women than all women between surveysconducted from 2003 to 2008 and 2008 to 2012 in the
same countries. The downward bias in prevalence among
pregnant women compared with not currently pregnant
women was around 18% across all countries, but the
difference was not statistically significant and CIs
for prevalence among pregnant women were large.
Using population sizes at the time of each survey to
de-normailze sampling weights in pooled analyses rather
than standardizing to 2012 population sizes had a
negligible effect on the results. Other data sources offer
the potential to improve the precision of these estimates,
such as population-based HIV cohort studies embedded
within demographic surveillance sites [20] and by
comparing national household survey prevalence trends
with the actual age-specific ANC HIV prevalence
surveillance data, which have larger samples of pregnant
women. Mathematical modelling will further elucidate
how biases may vary over time, with ART programme
scale-up, and across epidemics with different recent and
future HIV incidence trends [21].
Modelling will also quantify the potential magnitude of
biases in HIV incidence estimates resulting from down-
ward biases in prevalence among pregnant women.
National epidemic estimates for HIV incidence are
generated by fitting a model to HIV prevalence trends in
ANC data and using information about natural HIV
survival and ART uptake to determine what previous
incidence would be required to match the observed
prevalence. Thus, overestimating declines in HIV
prevalence based on trends in ANC data could also
overstate the extent towhichHIV incidence has declined.
Because recent prevalence patterns represent the
accumulation of HIV incidence and mortality from
several years previous, the relationship between the
magnitude of bias in prevalence trends and incidence
trends over the same period may vary across epidemics
and biases in prevalence trends in recent years may affect
estimates of HIV incidence in earlier periods.
HIV prevalence trends among women aged 15–24 years
who were currently pregnant were very similar to trends
for all women aged 15–24 years. This is consistent with
previous research finding that prevalence trends among
young women attending ANC were representative of
prevalence trends in all young women [11,22], which
justified the recommendation of using ANC prevalence
among women aged 15–24 years as proxy indicator for
recent incidence trends [23]. This may be inappropriate
going forward because an increasing proportion of
prevalence in young adults will be accounted for by
long-term survivors of mother-to-child HIV trans-
mission [24,25], particularly as paediatric ART pro-
grammes mature.
Among older adult women, however, prevalence in
pregnant women was significantly lower than in the
general population. The implication of this is that simply
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women to represent the age distribution of the general
population may not resolve the downward bias in HIV
prevalence trends among pregnant women. One reason
for the lower prevalence is thought to be the lower
fertility among HIV-positive pregnant women at older
ages [26–28]. To the extent that this subfertility is due to
the effects of HIV infection, antiretroviral treatment may
ameliorate HIV-related subfertility [29]. Thus, with high
levels of ART coverage, prevalence among older pregnant
women may again become more similar to general
population prevalence.
In light of the different age patterns of prevalence among
pregnant women and the general population and
potential future changes owing to ART, we recommend
that HIV prevalence surveillance among antenatal clinic
attendees should be stratified by age and whether HIV-
positive women were on ART prior to the pregnancy or
initiated ART during their pregnancy. The latter will
enable appropriate adjustment for the effects of ARTon
fertility when interpreting future ANC prevalence trends.
Ascertainment of ART status could be done anon-
ymously using biomarker testing for antiretrovirals on
blood samples from the first ANC visit [15,30], or
biomarker testing could be used to confirm self-reported
ART status. These recommendations for reporting ANC
prevalence also apply to sentinel surveillance in pregnant
women based on HIV testing for prevention of mother-
to-child transmission (PMTCT), which must additionally
ensure that women who opt out of PMTCT testing
because of prior knowledge of HIV status are reflected in
PMTCT surveillance reporting and that information on
ART status be collected for such women [31].
This analysis did not consider factors beyond pregnancy
that could influence the representativeness of HIV
prevalence trends among ANC attendees. These could
include changing patterns in ANC attendance over time
or systematic differences in ANC attendance according to
factors that are also correlated with risk of HIV infection,
such as education, socioeconomic status, parity, or
contraceptive use [6,32,33]. Although we found that
HIV prevalence among pregnant women was lower than
among all women, at the national level, HIV prevalence
derived from ANC surveillance has tended to over-
estimate general population prevalence [34]. Reasons for
this apparent discrepancy include: general population
prevalence includes men who tend to have a lower
prevalence than women [6], sites initially chosen for ANC
surveillance may have been in higher prevalence areas
[35], and potential systematic differences among women
who attend public antenatal clinics as opposed to those
who attend private facilities or do not attend any health
facility for their prenatal care.
Sentinel surveillance of HIV prevalence among pregnant
women attending antenatal care has been invaluable forquantifying HIVepidemics in sub-Saharan Africa and will
continue to be useful for informing HIV estimates.
However, naı¨ve interpretation of prevalence trends
among pregnant women as representative of all women
aged 15–49 years may lead to downward biases in model-
derived estimates of HIV prevalence and incidence in the
general population. To correct for this bias, HIV
incidence and prevalence estimates in the general popula-
tion should account for both the age-pattern of fertility
and the effects of HIV and ART on fertility when
interpreting trends in ANC prevalence.Acknowledgements
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